MiAlgae plans new production facility in Grangemouth to meet rising Omega-3 demand
Biotech company MiAlgae has submitted plans for a new production facility in Grangemouth, Scotland, as it seeks to scale up its production of microalgae-derived Omega-3s for use in aquaculture, pet food, and emerging markets.
The company, which repurposes by-products from the whisky industry to grow microalgae, said the new site will support increasing demand for sustainable alternatives to fish-derived Omega-3s. The Grangemouth location, close to both feedstock sources and customers in Scotland’s Central Belt, is expected to create more than 100 jobs in its first phase.
MiAlgae said the facility will also provide retraining opportunities for workers transitioning from the oil and gas sector. The modular site is designed to expand as demand increases, with additional facilities planned both in the UK and internationally.
Founder and managing director Douglas Martin said the Grangemouth site “offers an ideal position to support our scaling efforts and meet the increasing demand for our ‘biotech for good’ solutions.”
The company is working with manufacturing partner CalaChem on the project and is exploring further collaboration with the Scottish Government through initiatives such as Project Willow, which aims to attract green industries to the area.
MiAlgae’s expansion is intended to support growth into additional markets including nutraceuticals, meat alternatives, and livestock feed.